Innovative drug sector rose, Ha Sanlian hit the limit up.

Innovative drug sector surged, Halsun Pharma hit the limit up, Wanbang Pharma rose more than 10%, Jiu Zhitang, Kelun Pharma, and Kailaiying all surged.